TSO3 Inc (TOS) - Financial and Strategic SWOT Analysis Review

GlobalData
46 Pages - GLDATA63529
$125.00

TSO3 Inc (TOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

TSO3 Inc (TSO3) designs develops, manufactures, markets and licenses sterilization processes for heat-sensitive medical devices. The company’s area of focus is sterile processing, which provides a replacement solution to other low temperature sterilization processes used in hospitals. The company’s flagship product is Sterizone VP4 Sterilizer, a dual sterilant, low-temperature sterilization system, which utilizes vaporized hydrogen peroxide and ozone. The company’s product is based on its patented Sterizone sterilization platform. The company also offers services such as maintenance of sterilization equipment and compatibility testing of medical devices. The product finds use in hospitals and clinical settings with high patient turnover. TSO3 is headquartered in Quebec, Canada.

TSO3 Inc Key Recent Developments

May 08,2018: TSO3 Reports First Quarter 2018 Results
Apr 02,2018: TSO3 Appoints Dr. Douglas Dieter to its Board of Directors
Jan 25,2018: TSO3 Provides an Operational Update
Nov 06,2017: TSO3 Reports Record Third Quarter 2017 Results
Sep 25,2017: TSO3 Appoints Dr. Bradley J. Catalone as Chief Science Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

'

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
TSO3 Inc - Key Facts 5
TSO3 Inc - Key Employees 6
TSO3 Inc - Key Employee Biographies 7
TSO3 Inc - Major Products and Services 8
TSO3 Inc - History 9
TSO3 Inc - Company Statement 11
TSO3 Inc - Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 – Company Analysis 13
Company Overview 13
TSO3 Inc - Business Description 14
TSO3 Inc - SWOT Analysis 15
SWOT Analysis - Overview 15
TSO3 Inc - Strengths 15
TSO3 Inc - Weaknesses 16
TSO3 Inc - Opportunities 17
TSO3 Inc - Threats 18
TSO3 Inc - Key Competitors 19
Section 3 – Company Financial Ratios 20
Financial Ratios - Capital Market Ratios 20
Financial Ratios - Annual Ratios 21
Performance Chart 23
Financial Performance 23
Financial Ratios - Interim Ratios 24
Financial Ratios - Ratio Charts 25
Section 4 – Company’s Lifesciences Financial Deals and Alliances 26
TSO3 Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 26
TSO3 Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 27
TSO3 Inc, Recent Deals Summary 28
Section 5 – Company’s Recent Developments 29
May 08, 2018: TSO3 Reports First Quarter 2018 Results 29
Apr 02, 2018: TSO3 Appoints Dr. Douglas Dieter to its Board of Directors 30
Jan 25, 2018: TSO3 Provides an Operational Update 31
Nov 06, 2017: TSO3 Reports Record Third Quarter 2017 Results 33
Sep 25, 2017: TSO3 Appoints Dr. Bradley J. Catalone as Chief Science Officer 34
Aug 01, 2017: TSO3 Reports Record Second Quarter 2017 Results 35
May 10, 2017: TSO3 Reports Record First Quarter 2017 Results 36
Mar 21, 2017: TSO3 Reports Record Fourth Quarter and Full Year 2016 Results 38
Feb 16, 2017: TSO3 Appoints Dr. Linda Rosenstock and Mr. Jeffrey Pompeo to its Board of Directors 40
Feb 02, 2017: TSO3 Appoints Mark Pasmore as Vice President of Research and Development 41
Section 6 – Appendix 42
Methodology 42
Ratio Definitions 42
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
TSO3 Inc, Key Facts 5
TSO3 Inc, Key Employees 6
TSO3 Inc, Key Employee Biographies 7
TSO3 Inc, Major Products and Services 8
TSO3 Inc, History 9
TSO3 Inc, Subsidiaries 12
TSO3 Inc, Key Competitors 19
TSO3 Inc, Ratios based on current share price 20
TSO3 Inc, Annual Ratios 21
TSO3 Inc, Annual Ratios (Cont...1) 22
TSO3 Inc, Interim Ratios 24
TSO3 Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 26
TSO3 Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 27
TSO3 Inc, Recent Deals Summary 28
Currency Codes 42
Capital Market Ratios 42
Equity Ratios 43
Profitability Ratios 43
Cost Ratios 44
Liquidity Ratios 44
Leverage Ratios 45
Efficiency Ratios 45

List of Figures
TSO3 Inc, Performance Chart (2013 - 2017) 23
TSO3 Inc, Ratio Charts 25
TSO3 Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 26
TSO3 Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 27

$125.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838